文献速递流行病学与生物统计

竞争风险情境下Kaplan-Meier生存分析高估健康相关事件的累积发生率:一项Meta分析

Kaplan-Meier survival analysis overestimates cumulative incidence of health-related events in competing risk settings: a meta-analysis.
PubMed 文献 · J Clin Epidemiol · 2017-10-16

该系统综述与Meta分析检索MEDLINE、EMBASE、BIOSIS Previews、Web of Science(1992-2016)及文章参考文献,纳入77项研究并对其中的55项进行Meta分析,比较Kaplan-Meier法与累积发生率函数(CIF)估计的累积发生率。合并风险比显示Kaplan-Meier估计值比CIF高1.41倍(95%CI:1.36,1.47);在竞争风险率高、肝病学及妇产科相关研究中高估最明显。结论认为Kaplan-Meier法在10个临床领域均高估累积发生率,使用竞争风险方法可确保结果准确。

要点

  • Kaplan-Meier法估计的累积发生率是CIF的1.41倍(95%CI:1.36,1.47)。
  • 竞争风险率高时高估最明显,RR=2.36(95%CI:1.79,3.12)。
  • 肝病学相关研究RR=2.60(95%CI:2.12,3.19),妇产科相关研究RR=1.84(95%CI:1.52,2.23)。

核心结论

  • Kaplan-Meier法在10个临床领域均高估累积发生率,使用竞争风险方法可确保结果准确,为临床和政策决策提供依据。

研究设计与样本

  • 系统综述与Meta分析,检索MEDLINE、EMBASE、BIOSIS Previews、Web of Science(1992-2016)及文章参考文献,纳入77项研究,对其中55项进行Meta分析。
  • 使用DerSimonian and Laird随机效应模型计算合并风险比(RR),并按临床领域、竞争风险率(竞争风险/目标事件)和随访时间进行分层Meta分析。

主要发现

  • 合并RR显示Kaplan-Meier估计值比CIF高1.41倍(95%CI:1.36,1.47)。
  • 竞争风险率高的研究中高估最明显,RR=2.36(95%CI:1.79,3.12)。
  • 肝病学相关研究RR=2.60(95%CI:2.12,3.19),妇产科相关研究RR=1.84(95%CI:1.52,2.23)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Kaplan-Meier survival analysis overestimates cumulative incidence in competing risks (CRs) settings. The extent of overestimation (or its clinical significance) has been questioned, and CRs methods are infrequently used. This meta-analysis compares the Kaplan-Meier method to the cumulative incidence function (CIF), a CRs method. STUDY DESIGN AND SETTING: We searched MEDLINE, EMBASE, BIOSIS Previews, Web of Science (1992-2016), and article bibliographies for studies estimating cumulative incidence using the Kaplan-Meier method and CIF. For studies with sufficient data, we calculated pooled risk ratios (RRs) comparing Kaplan-Meier and CIF estimates using DerSimonian and Laird random effects models. We performed stratified meta-analyses by clinical area, rate of CRs (CRs/events of interest), and follow-up time. RESULTS: Of 2,192 identified abstracts, we included 77 studies in the systematic review and meta-analyzed 55. The pooled RR demonstrated the Kaplan-Meier estimate was 1.41 [95% confidence interval (CI): 1.36, 1.47] times higher than the CIF. Overestimation was highest among studies with high rates of CRs [RR = 2.36 (95% CI: 1.79, 3.12)], studies related to hepatology [RR = 2.60 (95% CI: 2.12, 3.19)], and obstetrics and gynecology [RR = 1.84 (95% CI: 1.52, 2.23)]. CONCLUSION: The Kaplan-Meier method overestimated the cumulative incidence across 10 clinical areas. Using CRs methods will ensure accurate results inform clinical and policy decisions.

来源:J Clin Epidemiol,查看原文。版权归原作者所有。

引用

  1. Lacny S, Wilson T, Clement F, et al. Kaplan-Meier survival analysis overestimates cumulative incidence of health-related events in competing risk settings: a meta-analysis. J Clin Epidemiol. 2017. PMID: 29045808. doi:10.1016/j.jclinepi.2017.10.006

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。